Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite study sheds light on anthelmintic resistance
The barber pole worm is resistant to major anthelmintics
Barber pole worm study offers hope for new treatments

A new study of the barber pole worm has offered insights into how treatments work and why anthelmintic resistance may occur.

Barber pole worm, or Haemonchus contortus, is a parasitic worm that lives in the gut of sheep and other livestock worldwide, and is now resistant to all major anthelmintics.

To find out how and why resistance has occurred, the research team studied a strain of H contortus that is susceptible to all major treatments for parasitic worms.

Scientists identified five enzymes key to the survival of the barber pole worm, two of which are already being studied as potential drug targets – one against another type of worm, the other against Mycobacterium tuberculosis.

According to funding institute the Wellcome Trust, the barber pole worm is endemic on all UK farms and is a significant threat to global food security. It is estimated to cost the UK sheep industry more than £80 million each year.

"Getting to grips with genomes such as that of H contortus is our best option to tackle the issue of drug resistance and develop new drugs against parasitic worms," said Professor Neil Sargison, study author from the University of Edinburgh's Royal (Dick) School of Veterinary Studies.

The research team also identified a set of genes that were more active within the parasite's gut, and at certain stages of its life cycle. It is hoped this information will offer a source of potential drug and vaccine candidates.

Co-author Professor Jon Gilleard, of the University of Calgary, said: "Not only is this worm closely related to many other parasites of livestock it is also similar to some species of worms in humans.

"This makes it an extremely important model parasite species for experimental studies. Revealing new drug targets against H contortus could provide much-needed new treatment opportunities against parasitic worms in both animals and humans."

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.